Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hmm and nwbo unfortunately is missing the efficacy portion. Graced by your newbie forever presence.
That is pretty fresh coming from dot connector extraodraire
All signs point to nwbo funding advent. And that's it.
This isn't getting approved. Fat cat LP pulled the wool over what little real nwbo sheep there are. The denial will happen in 2025
You don't know how NICE operates now do you newbie. Stop making BS claims you know nothing about. Stick to your nonsense dot connecting.
Give it up with this lease BS.. Ardvent collects 150k per patient. What is the revenue split with nwbo?
How much do you all get paid to promote this lease and property BS? Still don't know much after all these years. This is what happens when you are approaching 2b shares authorized. These idiots feel entitled to owning 20% of the company shares
Fool me once with cognate, shame on you to get fooled with advent.
have you checked the NICE max yearly authorizations for CAR-T.....it is in the 100s. 12k not happening in the UK. yall need to realize, the UK is not where you go for higher priced therapies if you are looking for reimbursement from NICE.
i don't get this naive level of thinking. Their main purpose is to build out there CDMO and give themselves millions and millions of dollars worth of cheap options. They excel at these. The rest is all noise to distract and deflect. They probably throw pumpers on here to do a lot of this distract and deflect. No one cares about the revenue split with ADVENT. I find that incredible. Revenues don't matter. This company is about compassion and saving lives and fighting evil MM forces holding them back. Externalize all of your shortcomings. Blame the critics, and call them FUD. Never ending eye rolls man here.
A lesson to be learned here for the real retail will wary AF to ever buy an OTC again once this all plays out. You get what you pay for.
more dot connecting.....incredible.
No buyout is coming sorry to burst your dot connecting bubble.
Broke, non-executing, trial full of warts, dilution to fund CDMO owned not by NWBO, even if by hail mary they get approved there is no path to profitablity in the UK (not NICE)
Sorry you all been fooled one too many times.
I dont post BS like 45% penetration of total CNS market penetration in the UK for your bogus projections. Reimbursement anyone? Billions for the UK my ()().
Biggest pumper on this board. Post that BS again. I'll dig it up later.....most pathetic attempt at sales number/valutuation I ever seen.
Please stop this BS talk of automation. The automation is not stopping any approval. The trials were done with manual method. Nwbo itself says itself in the last BS PR fluff piece they are still testing their stupid automation. These approvals will be manual. Stop pumping this automation BS. Are you paid by the company to put out hopium?
So much distract and deflect.....the real point is the manual approval all this other BS MM, revimmune, patents, combos, automation are meaningless if this manual application gets rejected.
The company themselves admits to the difficulties of reimbursement in Europe. And when I say it, it is FUD. Hahahaha. Go look up how NICE sets a hard limit of CAR-T in max authorizations and that number is in the 100s. And what was bioharm projecting for this drug in the UK? That dude is such a pumper. It isn't even funny.
And you sheep wonder why the US is the top dog in revenues by a landslide. Repeat after me REIMBURSEMENT REIMBURSEMENT REIMBURSEMENT
Means DILUTION DILUTION DILUTION
2.2B shares authorized request incoming.......cue it. Cause self funding revenues aren't coming even if this is UK approved.
So is this sec filing quote from nwbo themselves FUD? Sounds like what I wrote....US reimbursement is by far the most generous and it why US revenues account for over 50% of worldwide totals.
Here let's cherry pick our own questions and answer only those. We don't have an open q&a because we just don't have any analysts who care to follow us and the one analyst we used to pay to pump is now on our BOD. You cant make this BS up if you wanted.
UK is a tiny market mostly because their reimbursement is crap (see car-t for example). It is doubtful that this UK market and NICE can bring any meaningful revenue in the foreseeable future. So that means more of the same daily dilution. The company needs to ask for more authorized shares soon. When this thing hits 2b plus authorized shares, $1 PPS equates to 2B valuation. And that isn't happening from the UK alone. Realistically speaking if you get a pump to $1, get out and don't ever look back.
Ask yourself, how long will it take to submit an FDA application? Do you think it will be quick, doubtful. And do you think this current team can actually market a complex autologous product with logistical challenges, also doubtful. I don't see anyone on their team with witb any biotech or pharma sales experience. You gotta be honest with yourself here and evaluate.
Go to that fudster well when you can't refute me and when in doubt. Nice.
Does it guarantee approval of a trial with changed endpoints? Nope. Is the application accepted yet? I forgot the company doesn't inform shareholders.....only when they want to pump their flubbed application
Jama article means approval.....noted. lmfao. Thank you Count bala for your fantastic insight and paid pumping.
CAR-T is only authorized for up to 100 or so patients by NICE. And people are expecting NWBO to make money without reimbursement. Good luck with that hopium. Dilution contuing for the foreseeable future. $1 or less is realistic for this non revunue producing market. No reimbursement = No Bueno. Nwbo has never been about making revenue or helping patients. It has always been about helping LP and friends build Out advent. Newbie investors or real retail.....There is a reason the US funds biotech research, you get premium pricing and reimbursement.
The paid pumpers are far worse. They are so far outside of reality and pump hopium that is harmful for any real retail in this stock. At least the bashers have legitimate arguments.
Refute it instead of calling fud. You cant, can you? When in doubt call fud....that's what the company pays you to do.
OK the king is going to take an unapproved med. Noted. More bread crumbs. Unreal the imagination of you dot connectors.....
Because she gets another paycheck and this is the company who has her commercial rights. Not really hard to comprehend. Don't read too much into that. Just more breadcrumb hunting.
Because that would have tanked the stock. And they knew it. Try as they might to disguise the fact they claim they didn't know the primary failed......you don't pivot endpoints at the end of the trial. That just kills the integrity of the trial. They would have been laughed out of the fda. This going to the mhra is last ditch hail Mary. But the real intent was to build out advent and buy more time and suckers to fund it. Total scam. Will never get fda approved which means never will be profitable. NICE is only approving a max of 180 or so patients this year on CAR-T. So not even sure why they are even going to mhra because that guarantees continued dilution for the foreseeable future.
Rfi has nothing to do with familiarity by the mhra. The approval is based on the application and if it isn't complete or clear, then the regulatory agency asks for additional information. Past performance should dictate that nwbo can't submit anything right or in a timely fashion. Rfi is guaranteed they even talk about it in the sec filings.....hint hint.
And what does you owning shares for 9 years have anything to do with this? That means you know what fully diluted share count is and that they need to ask for more very soon. Why? Because nwbo is funding advent and they have run out of shares to print because no revenue is in sight. It is a scam. You own this stock for 9 years and been diluted to oblivion. Shame on you for not having a brain.
25$ per share with current fully diluted 1.7b share authorized? And soon to be 2b plus (and yes it is coming). Think about market cap in this abnormally large share count.....$25 will never happen. Please stop promoting this kind of BS. This stock will never even see double digits in your lifetime.
Yeah exactly you get an pdufa and/or an adcom date with the fda and similar with ema. You can use vertex as a guide as to how long it would take in the UK. They submitted in dec and got approved in November and that was without an RFI. You can be rest assured NWBO will get an RFi since they can't do anything right. So that's how you can deduct 2025 for the UK decision.
i wonder who that person you are referring to is? BIOHARM?
Cue that boy.
Yeah you should be planning, but NWBO has no intention of marketing this product. Build it and they will come. That is such a laughable statement that only a naive person would make about an autologous products/process. I thought this company learned from DNDN's mistakes....please. So much BS on this board it is incredible.
You are effing genius bro. 70% of trades are done by computers/algos.
You are most definitely a pump. There is no doubt. So many paid pumps here......
Cutting losers is not an odd strategy.
What is odd is that you pumpers guilt trip him into fomo. It is just a few months away. It been this way for many many years......on the 1 yard line for 10 years. Okay pumper..
The NICE Coverage is not even going be an issue. But in event that it is. NICE limits the number of patients (see below for CAR-t). I think the disciples calculate some ridiculous number for UK patients. But sht it is going to be a moot point because this is going to get denied in the approval stage.
NICE is authorizing a whopping 215 adult patients in LBCL and 75 in ALL with CAR-T. Eye MFing rolls.
Did the disciples not understand why revenues in UK are low? Reimbursement, Reimbursement, Reimbursement. LMFAO. Sorry this coming to the UK first was about ADVENT. Sorry pumpers....Aint no revenue coming anytime soon, oh i forgot Advent gets the revenues......
the imagination of these pumpers.....LOL
They did a flurry of PRs when they couldn't submit on time. That's about as good as it is going to get in NWBO PR land. PRs for their excuses why they couldn't submit on their self imposed timeline that was years late already. No credibility whatsoever........zero
What rock you been living under? Time for you to up your DD. You didn't know Advent owned by LP and her fund. SMFH.
How better to keep self deal alive to revimmune when advent and cognate weren't enough. Have your paid pumps generate some hype around this early stage data and company. We can pivot to combination therapy and kick the goal posts 200 more yards down the road. Let's keep continuing this conflict of interest scam to more unsuspecting retail. Keep adding fleas to this POS. The story keeps getting better and better.....unbelievable. And you all wonder why you are on the POS OTC.
All this is noise....the only thing that can save this is both approval and buyout. Approval alone is not even enough with no path to profitability.
all you got is out in universe dot connecting. Is this the first stock you ever owned? Where do you get this imagination that allows you connect BP dots to NWBO? You are a dreamer, i get it. You own 25k shares or less? Your lesson won't be that expensive fortunately.